SavedAdd your journal

Journals / European Journal of Rheumatology / 2017 / Cilt: 4 - Sayı: 1

Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility

Orhan KÜÇÜKŞAHİN
Ufuk İLGEN
Pages
66–67
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we report a case of FMF with infertility who became pregnant with in vitro fertilization (IVF) under treatment with anakinra, along with the pregnancy outcome

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Familial Mediterranean fever (FMF), affecting people of Mediterranean origin, is an endemic and sometimes problematic disease because of colchicine resistance/intolerance, with relative lack of treatment alternatives, and disease- or treatment-related issues, such as subfertility.
📊
Key Findings & Data:Anakinra, being a rational and effective treatment alternative, has no conclusive human pregnancy data.
💡
Conclusion & Impact:Here we report a case of FMF with infertility who became pregnant with in vitro fertilization (IVF) under treatment with anakinra, along with the pregnancy outcome
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Familial Mediterranean fever (FMF), affecting people of Mediterranean origin, is an endemic and sometimes problematic disease because of colchicine resistance/intolerance, with relative lack of treatment alternatives, and disease- or treatment-related issues, such as subfertility. Anakinra, being a rational and effective treatment alternative, has no conclusive human pregnancy data. Here we report a case of FMF with infertility who became pregnant with in vitro fertilization (IVF) under treatment with anakinra, along with the pregnancy outcome

🔖

Cite This Article

KÜÇÜKŞAHİN, O., İLGEN, U. (2022). Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility. European Journal of Rheumatology, Cilt: 4 - Sayı: 1, 66–67. https://ajindex.com/articles/511728

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Heng YJ, Liong S, Permezel M, Rice GE, Di Quinzio MK, Georgiou HM. The interplay of interleukin-1 system in pregnancy and labor. Reprod Sci 2011; 21: 122-30. [CrossRef] 2. Berger CT, Recher M, Steiner U, Hauser TM. A patient’s wish: anakinra in pregnancy. Ann Rheum Dis 2009; 68: 1794-5. [CrossRef] 3. Fischer-Betz R, Specker C, Schneider M. Successfull outcome of two pregnancies in patients with adult onset Still’s disease treated with IL-1 receptor antagonist (anakinra). Clin Exp Rheumatol 2011; 29: 1021-3. 4. Ozdogan H, Ugurlu S, Ergezen B. The pregnancy outcomes in patients who are exposed to IL-1 blockade with anakinra. Ann Rheum Dis 2015; 74: 400-1. [CrossRef] 5. Chang Z, Spong CY, Jesus AA, Davis MA, Plass N, Stone DL, et al. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS). Arthritis Rheumatol 2014; 66: 3227-32. [CrossRef] 6. Lachman HJ, Ozdogan H, Simon A, Stewart N, Rowczenio DM, Uğurlu S, et al. Anti IL-1 therapies and pregnancy outcome. Pediatr Rheumatol Online J 2013; 1(Suppl 1): A269. [CrossRef] 7. Prutsch N, Fock V, Haslinger P, Haider S, Fiala C, Pollheimer C, et al. The role of interleukin-1β in human trophoblast motility. Placenta 2012; 33: 696-703. [CrossRef] 8. Girard S, Tremblay L, Lepage M, Sebire G. Early detection of placental inflammation by MRI enabling protection by clinically relevant IL-1Ra administration. Am J Obstet Gynecol 2012; 206: 358.e1-9. [CrossRef] 9. Ruiz RJ, Jallo N, Murphey J, Marti CN, Godbold E, Pickler RH. Second trimester maternal plasma levels of cytokines IL1Ra, IL-6 and IL-10 and preterm birth. J Perinatonol 2012; 32: 483-90. [CrossRef] 10. Mijatovic M, Hompes PG, Wouters MG. Familial Mediterranean Fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 108: 171-6. [CrossRef]